Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Helsen

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2026
Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid TumorsEcaterina E Dumbrava, Daniel Olson, Mohamed A Gouda, et al.
Nature Communications|August 5, 2018
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicityChristopher W Helsen, Joanne A Hammill, Vivian W C Lau, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2026
Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid TumorsEcaterina E Dumbrava, Daniel Olson, Mohamed A Gouda, et al.
Nature Communications|August 5, 2018
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicityChristopher W Helsen, Joanne A Hammill, Vivian W C Lau, et al.
Pageof 2